{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:03:25Z","timestamp":1759334605069,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.arcmed.2008.04.004","type":"journal-article","created":{"date-parts":[[2008,5,29]],"date-time":"2008-05-29T05:52:19Z","timestamp":1212040339000},"page":"541-545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Multidrug Resistance-1 in T Lymphocytes and Natural Killer Cells of Adults with Idiopathic Thrombocytopenic Purpura: Effect of Prednisone Treatment"],"prefix":"10.1016","volume":"39","author":[{"given":"Xavier","family":"L\u00f3pez-Karpovitch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Graue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erick","family":"Crespo-Sol\u00eds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josefa","family":"Piedras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2008.04.004_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/tmrv.2003.50004","article-title":"Cellular immune mechanisms in autoimmune thrombocytopenic purpura: an update","volume":"17","author":"Coopamah","year":"2003","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.arcmed.2008.04.004_bib2","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1182\/blood.V87.10.4245.bloodjournal87104245","article-title":"Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity","volume":"87","author":"Semple","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2008.04.004_bib3","first-page":"914","article-title":"Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura","volume":"90","author":"Wang","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.arcmed.2008.04.004_bib4","first-page":"387","article-title":"Polarization and apoptosis of T cell subsets in idiopathic thrombocytopenic purpura","volume":"2","author":"Liu","year":"2005","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.arcmed.2008.04.004_bib5","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1046\/j.1365-2141.1996.d01-1967.x","article-title":"Oligoclonal accumulation of T cells in peripheral blood from patients with idiopathic thrombocytopenic purpura","volume":"95","author":"Shinomura","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.arcmed.2008.04.004_bib6","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1182\/blood-2007-02-068999","article-title":"Response to B-cell-depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura","volume":"110","author":"Stasi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2008.04.004_bib7","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2008.04.004_bib8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.bi.62.070193.002125","article-title":"Biochemestry of multidrug resistance mediated by the multidrug transporter","volume":"62","author":"Gottesman","year":"1993","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.arcmed.2008.04.004_bib9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1677\/joe.0.1780339","article-title":"Mechanism of steroid action and resistance in inflammation","volume":"178","author":"Farrell","year":"2003","journal-title":"J Endocrinol"},{"key":"10.1016\/j.arcmed.2008.04.004_bib10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1046\/j.1365-2141.1998.00751.x","article-title":"Differential activity of P-glycoprotein in normal blood lymphocyte subsets","volume":"101","author":"Ludescher","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.arcmed.2008.04.004_bib11","first-page":"40","article-title":"Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders II. Increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control","volume":"67","author":"D\u00edaz-Borjon","year":"2000","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.arcmed.2008.04.004_bib12","first-page":"30","article-title":"Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders I. Increased P-glycoprotein activity in lymphocytes from rheumatoid arthritis patients might influence disease outcome","volume":"67","author":"Llorente","year":"2000","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.arcmed.2008.04.004_bib13","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/rheumatology\/35.5.430","article-title":"Expression of the multidrug resistance glycoprotein 170 in the peripheral blood lymphocytes of rheumatoid arthritis patients. The percentage of lymphocytes expressing glycoprotein 170 is increased in patients treated with prednisone","volume":"35","author":"Maillefert","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.arcmed.2008.04.004_bib14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.biopha.2004.04.008","article-title":"Multidrug resistance-1 (MDR-1) in autoimmune disorders IV. P-glycoprotein overfunction in lymphocytes from myasthenia gravis patients","volume":"58","author":"Richaud-Patin","year":"2004","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.arcmed.2008.04.004_bib15","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1046\/j.1365-2141.2002.03709.x","article-title":"High P-glycoprotein-mediated export observed in patients with a history of idiopathic thrombocytopenic purpura","volume":"118","author":"Levy","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.arcmed.2008.04.004_bib16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0301-472X(03)00074-2","article-title":"Multidrug resistance-1 (MDR-1) in autoimmune disorders. III: Increased P-glycoprotein activity in lymphocytes from immune thrombocytopenic purpura patients","volume":"31","author":"Ruiz-Soto","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.arcmed.2008.04.004_bib17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/(SICI)1097-0320(19981215)34:6<248::AID-CYTO2>3.0.CO;2-X","article-title":"Reference method for detection of Pgp mediated multidrug resistance in human hematological malignancies: a method validated by the laboratories of the French drug resistance network","volume":"34","author":"Huet","year":"1998","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.arcmed.2008.04.004_bib18","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1182\/blood-2001-12-0371","article-title":"MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia","volume":"100","author":"Tafuri","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2008.04.004_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","article-title":"Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology","volume":"88","author":"George","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2008.04.004_bib20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0002-9343(80)90016-9","article-title":"Adult idiopathic thrombocytopenic purpura: clinical findings and response to therapy","volume":"69","author":"DiFino","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.arcmed.2008.04.004_bib21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF00918857","article-title":"Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: a role in cytotoxic effector function","volume":"12","author":"Gupta","year":"1992","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.arcmed.2008.04.004_bib22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0889-8588(01)00016-8","article-title":"Monitoring of cellular resistance to cancer chemotherapy","volume":"16","author":"Krishan","year":"2002","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.arcmed.2008.04.004_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF02110331","article-title":"Effect of phosphorylation of P-glycoprotein on multidrug resistance","volume":"27","author":"Germann","year":"1995","journal-title":"J\u00a0Bioenerg Biomembr"},{"key":"10.1016\/j.arcmed.2008.04.004_bib24","doi-asserted-by":"crossref","first-page":"13668","DOI":"10.1074\/jbc.271.23.13668","article-title":"Protein kinase C-mediated phosphorylation does not regulate drug transport by the human multidrug resistance P-glycoprotein","volume":"271","author":"Goodfellow","year":"1996","journal-title":"J Biol Chem"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440908001082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440908001082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:35:09Z","timestamp":1759260909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440908001082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0188440908001082"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2008.04.004","relation":{},"ISSN":["0188-4409"],"issn-type":[{"type":"print","value":"0188-4409"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multidrug Resistance-1 in T Lymphocytes and Natural Killer Cells of Adults with Idiopathic Thrombocytopenic Purpura: Effect of Prednisone Treatment","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2008.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}